Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers
doi: 10.1016/j.hermed.2022.100539
Space-station study points to mitochondria News How does Make America Healthy Again hold up against scientific scrutiny
WeightWatchers says its GLP-1 program was developed by its team of obesity specialists, clinicians, behavior-change scientists, dietitians and fitness experts and solves a gap in the market as new weight loss medications take off
Findings in different studies indicate that Garcinia cambogia and Glucomannan therapy in individuals with overweight or obesity (across varying ages, sexes, and metabolic conditions) led to meaningful improvements in body composition and metabolic health
Since Retatrutide targets glucagon receptors, increasing insulin sensitivity and reducing blood sugar, it could be an effective treatment for people with type 2 diabetes (1)